Home / Companies / Ultragenyx Pharmaceutical Inc. / 15 May 2025
Ultragenyx Pharmaceutical Inc.: meeting of 15 May 2025
Votes reported on Form N-PX, item by item
485 Form N-PX filers reported votes at the Ultragenyx Pharmaceutical Inc. meeting of 15 May 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 86.4% of reported votes for; 38 filers withheld from or voted against at least one nominee.
614 vote records from 173 filers. 11 of the 173 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
681 vote records from 485 filers. 219 of the 471 filers that marked the item either way voted against management. 14 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
305 vote records from 172 filers. 3 of the 172 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
309 vote records from 175 filers. 88 of the 175 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | For | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | For | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | Split or no vote | For | For |
| Equitable | Abstain or withhold * | Against * | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | No report | Against * | No report |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Split or no vote | Against * | For |
| WisdomTree | For | For | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | For | For | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | Against | For |
| Voya | For | For | For |
| First Trust | For | Against * | For |
| Russell Investments | For | For | For |
| Victory Capital | For | Against * | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | For | Against * | For |
| Principal | Abstain or withhold * | Against * | For |
| Pacific Life funds | For | Against * | For |
| Global X | For | For | For |
| MFS | Split or no vote | Against * | For |
| Transamerica | For | For | For |
| Federated Hermes | For | For | For |
| AllianceBernstein | Abstain or withhold * | Against * | For |
| Hartford Funds | For | For | For |
| DWS | For | Against * | For |
| Allspring | For | Against * | For |
| MassMutual | For | For | For |
| Virtus | For | Against * | For |
| Macquarie and Delaware Funds | For | Against * | For |
| Neuberger Berman | No report | For | No report |
| Natixis and Loomis Sayles | For | For | For |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Ultragenyx Pharmaceutical Inc. meeting?
485 Form N-PX filers reported votes at the meeting of 15 May 2025. On say-on-pay, 219 of 471 voted against management (46.5%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Ultragenyx Pharmaceutical Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Ultragenyx Pharmaceutical Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Ultragenyx Pharmaceutical Inc. with a meeting date within three days of 15 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.